{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:35:16Z","timestamp":1761093316959,"version":"build-2065373602"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 2022JJ50023"],"award-info":[{"award-number":["No. 2022JJ50023"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Research Foundation of Education Bureau of Hunan Province, China","award":["No. 22A0065"],"award-info":[{"award-number":["No. 22A0065"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04332-w","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:02:43Z","timestamp":1761040963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic dynamics and stage-specific biomarkers in chronic HBV infection: a metabolomics study"],"prefix":"10.1186","volume":"25","author":[{"given":"Lizhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zifei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cunyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"4332_CR1","unstructured":"World Health Organization. Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries. Geneva: World Health Organization; 2024."},{"key":"4332_CR2","unstructured":"World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection (2024). 2024."},{"issue":"1","key":"4332_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00430-014-0369-7","volume":"204","author":"K Busch","year":"2015","unstructured":"Busch K, Thimme R. Natural history of chronic hepatitis B virus infection. Med Microbiol Immunol. 2015;204(1):5\u201310.","journal-title":"Med Microbiol Immunol"},{"issue":"2","key":"4332_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.21724","volume":"46","author":"CK Hui","year":"2007","unstructured":"Hui CK, Leung N, Yuen ST, Zhang HY, Leung KW, Lu L, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007;46(2):395\u2013401.","journal-title":"Hepatology"},{"key":"4332_CR5","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL). EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-398.","DOI":"10.1016\/j.jhep.2017.03.021"},{"issue":"3","key":"4332_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/jvh.13452","volume":"28","author":"C Campbell","year":"2021","unstructured":"Campbell C, Wang T, McNaughton AL, Barnes E, Matthews PC. Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysis. J Viral Hepat. 2021;28(3):493\u2013507.","journal-title":"J Viral Hepat"},{"issue":"8","key":"4332_CR7","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","volume":"20","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Li X, Le MH, Le AK, Yeo YH, Trinh HN, et al. Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase. Clin Gastroenterol Hepatol. 2022;20(8):1803-1812.e1805.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"4332_CR8","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/v15051212","volume":"15","author":"X Xu","year":"2023","unstructured":"Xu X, Wang H, Shan S, Sun Y, Xu X, You H, et al. On behalf of the China registry of hepatitis BC-HG: the impact of the definitions of clinical phases on the profiles of grey-zone patients with chronic hepatitis B virus infection. Viruses. 2023;15(5):1212.","journal-title":"Viruses"},{"issue":"21","key":"4332_CR9","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts E, Gannon M, Wasserman DH. The liver. Curr Biol. 2017;27(21):R1147-r1151.","journal-title":"Curr Biol"},{"issue":"6","key":"4332_CR10","first-page":"401","volume":"15","author":"Chinese Society of Hepatology CSoID","year":"2022","unstructured":"Chinese Society of Hepatology CSoID. Guidelines for the prevention and treatment of chronic hepatitis B (2022 Version). Chin J Clin Infect Dis. 2022;15(6):401\u201327.","journal-title":"Chin J Clin Infect Dis"},{"issue":"18","key":"4332_CR11","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.3390\/ijms251810144","volume":"25","author":"NJ Daniels","year":"2024","unstructured":"Daniels NJ, Hershberger CE, Kerosky M, Wehrle CJ, Raj R, Aykun N, et al. Biomarker discovery in liver disease using untargeted metabolomics in plasma and saliva. Int J Mol Sci. 2024;25(18):10144.","journal-title":"Int J Mol Sci"},{"key":"4332_CR12","doi-asserted-by":"publisher","first-page":"120038","DOI":"10.1016\/j.cca.2024.120038","volume":"566","author":"P Singh","year":"2025","unstructured":"Singh P, Singh R, Pasricha C, Kumari P. Navigating liver health with metabolomics: a comprehensive review. Clin Chim Acta. 2025;566:120038.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4332_CR13","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1080\/10408347.2020.1842172","volume":"52","author":"J Tang","year":"2022","unstructured":"Tang J, Xiong K, Zhang T, Han H. Application of metabolomics in diagnosis and treatment of chronic liver diseases. Crit Rev Anal Chem. 2022;52(5):906\u201316.","journal-title":"Crit Rev Anal Chem"},{"issue":"6","key":"4332_CR14","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.numecd.2021.01.008","volume":"31","author":"A Di Minno","year":"2021","unstructured":"Di Minno A, Gelzo M, Stornaiuolo M, Ruoppolo M, Castaldo G. The evolving landscape of untargeted metabolomics. Nutr Metab Cardiovasc Dis. 2021;31(6):1645\u201352.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"4332_CR15","first-page":"893","volume":"40","author":"China NHCotPsRo","year":"2024","unstructured":"China NHCotPsRo. Standard for diagnosis and treatment of primary liver cancer. J Clin Hepatol. 2024;40(5):893\u2013918.","journal-title":"J Clin Hepatol."},{"issue":"11","key":"4332_CR16","doi-asserted-by":"publisher","first-page":"21328","DOI":"10.3390\/ijms141121328","volume":"14","author":"L Kubicova","year":"2013","unstructured":"Kubicova L, Hadacek F, Chobot V. Quinolinic acid: neurotoxin or oxidative stress modulator? Int J Mol Sci. 2013;14(11):21328\u201338.","journal-title":"Int J Mol Sci"},{"key":"4332_CR17","doi-asserted-by":"publisher","first-page":"1070435","DOI":"10.3389\/fnut.2022.1070435","volume":"9","author":"MC Saade","year":"2022","unstructured":"Saade MC, Clark AJ, Parikh SM. States of quinolinic acid excess in urine: a systematic review of human studies. Front Nutr. 2022;9:1070435.","journal-title":"Front Nutr"},{"issue":"1","key":"4332_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/clinchem\/25.1.75","volume":"25","author":"LM Shaw","year":"1979","unstructured":"Shaw LM, Newman DA. Hydrolysis of glutathione by human liver gamma-glutamyltransferase. Clin Chem. 1979;25(1):75\u20139.","journal-title":"Clin Chem"},{"key":"4332_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.abb.2015.11.023","volume":"595","author":"M Inoue","year":"2016","unstructured":"Inoue M. Glutathionists in the battlefield of gamma-glutamyl cycle. Arch Biochem Biophys. 2016;595:61\u20133.","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"4332_CR20","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1006\/bbrc.2000.3585","volume":"276","author":"MJ Accaoui","year":"2000","unstructured":"Accaoui MJ, Enoiu M, Mergny M, Masson C, Dominici S, Wellman M, et al. Gamma-glutamyltranspeptidase-dependent glutathione catabolism results in activation of NF-kB. Biochem Biophys Res Commun. 2000;276(3):1062\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"4332_CR21","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jsps.2020.08.022","volume":"28","author":"AA Azouz","year":"2020","unstructured":"Azouz AA, Abdel-Nassir Abdel-Razek E, Abo-Youssef AM. Amlodipine alleviates cisplatin-induced nephrotoxicity in rats through gamma-glutamyl transpeptidase (GGT) enzyme inhibition, associated with regulation of Nrf2\/HO-1, MAPK\/NF-\u03baB, and Bax\/Bcl-2 signaling. Saudi Pharm J. 2020;28(11):1317\u201325.","journal-title":"Saudi Pharm J"},{"issue":"23","key":"4332_CR22","doi-asserted-by":"publisher","first-page":"11123","DOI":"10.1158\/0008-5472.CAN-07-3061","volume":"67","author":"J Lin","year":"2007","unstructured":"Lin J, Manson JE, Selhub J, Buring JE, Zhang SM. Plasma cysteinylglycine levels and breast cancer risk in women. Cancer Res. 2007;67(23):11123\u20137.","journal-title":"Cancer Res"},{"issue":"3","key":"4332_CR23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3945\/ajcn.115.125799","volume":"104","author":"EH Miranti","year":"2016","unstructured":"Miranti EH, Freedman ND, Weinstein SJ, Abnet CC, Selhub J, Murphy G, et al. Prospective study of serum cysteine and cysteinylglycine and cancer of the head and neck, esophagus, and stomach in a cohort of male smokers. Am J Clin Nutr. 2016;104(3):686\u201393.","journal-title":"Am J Clin Nutr"},{"key":"4332_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.vh.2022.10.008","volume":"121","author":"A G\u0119gotek","year":"2023","unstructured":"G\u0119gotek A, Skrzydlewska E. Ascorbic acid as antioxidant. Vitam Horm. 2023;121:247\u201370.","journal-title":"Vitam Horm"},{"issue":"1","key":"4332_CR25","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.iliver.2022.03.001","volume":"1","author":"S Patel","year":"2022","unstructured":"Patel S, Chaturvedi A, Dubey N, Shrivastava A, Ganeshpurkar A. Ascorbic acid ameliorates isoniazid-rifampicin-induced hepatocellular damage in rats. Iliver. 2022;1(1):72\u20137.","journal-title":"Iliver"},{"issue":"3","key":"4332_CR26","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0006-291X(03)00811-8","volume":"305","author":"R Brigelius-Floh\u00e9","year":"2003","unstructured":"Brigelius-Floh\u00e9 R. Vitamin E and drug metabolism. Biochem Biophys Res Commun. 2003;305(3):737\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"4332_CR27","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/1071576021000005357","volume":"36","author":"A Betancor-Fernandez","year":"2002","unstructured":"Betancor-Fernandez A, Sies H, Stahl W, Polidori MC. In vitro antioxidant activity of 2,5,7,8-tetramethyl-2-(2\u2019-carboxyethyl)-6-hydroxychroman (alpha-CEHC), a vitamin E metabolite. Free Radic Res. 2002;36(8):915\u201321.","journal-title":"Free Radic Res"},{"key":"4332_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.freeradbiomed.2021.12.012","volume":"178","author":"Q Jiang","year":"2022","unstructured":"Jiang Q, Im S, Wagner JG, Hernandez ML, Peden DB. Gamma-tocopherol, a major form of vitamin E in diets: insights into antioxidant and anti-inflammatory effects, mechanisms, and roles in disease management. Free Radic Biol Med. 2022;178:347\u201359.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"4332_CR29","doi-asserted-by":"publisher","first-page":"H721","DOI":"10.1152\/ajpheart.01089.2010","volume":"301","author":"K Noguchi","year":"2011","unstructured":"Noguchi K, Hamadate N, Matsuzaki T, Sakanashi M, Nakasone J, Uchida T, et al. Increasing dihydrobiopterin causes dysfunction of endothelial nitric oxide synthase in rats in vivo. Am J Physiol Heart Circ Physiol. 2011;301(3):H721-729.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4332_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25189890","author":"I Hernandez-Navarro","year":"2024","unstructured":"Hernandez-Navarro I, Botana L, Diez-Mata J, Tesoro L, Jimenez-Guirado B, Gonzalez-Cucharero C, et al. Replicative endothelial cell senescence may lead to endothelial dysfunction by increasing the BH2\/BH4 ratio induced by oxidative stress, reducing BH4 availability, and decreasing the expression of eNOS. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25189890.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4332_CR31","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1134\/S0006297922080132","volume":"87","author":"TA Kurgina","year":"2022","unstructured":"Kurgina TA, Shram SI, Kutuzov MM, Abramova TV, Shcherbakova TA, Maltseva EA, et al. Inhibitory effects of 7-methylguanine and its metabolite 8-hydroxy-7-methylguanine on human poly(ADP-ribose) polymerase 1. Biochemistry (Mosc). 2022;87(8):823\u201331.","journal-title":"Biochemistry (Mosc)"},{"issue":"6","key":"4332_CR32","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1134\/S0006297923060068","volume":"88","author":"SI Shram","year":"2023","unstructured":"Shram SI, Shcherbakova TA, Abramova TV, Baradieva EC, Efremova AS, Smirnovskaya MS, et al. Natural guanine derivatives exert PARP-inhibitory and cytoprotective effects in a model of cardiomyocyte damage under oxidative stress. Biochemistry (Mosc). 2023;88(6):783\u201391.","journal-title":"Biochemistry (Mosc)"},{"issue":"Pt 2","key":"4332_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/bj3420249","volume":"342","author":"D D'Amours","year":"1999","unstructured":"D\u2019Amours D, Desnoyers S, D\u2019Silva I, Poirier GG. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342(Pt 2):249\u201368.","journal-title":"Biochem J."},{"key":"4332_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jss.2021.09.008","volume":"270","author":"S Haga","year":"2022","unstructured":"Haga S, Kanno A, Morita N, Jin S, Matoba K, Ozawa T, et al. Poly(ADP-ribose) polymerase (PARP) is critically involved in liver ischemia\/reperfusion-injury. J Surg Res. 2022;270:124\u201338.","journal-title":"J Surg Res"},{"issue":"1\u20132","key":"4332_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1053\/j.seminoncol.2023.09.003","volume":"51","author":"O Longoria","year":"2024","unstructured":"Longoria O, Beije N, de Bono JS. PARP inhibitors for prostate cancer. Semin Oncol. 2024;51(1\u20132):25\u201335.","journal-title":"Semin Oncol"},{"key":"4332_CR36","doi-asserted-by":"publisher","first-page":"1234973","DOI":"10.3389\/fphar.2023.1234973","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun C, Chu A, Song R, Liu S, Chai T, Wang X, et al. PARP inhibitors combined with radiotherapy: are we ready? Front Pharmacol. 2023;14:1234973.","journal-title":"Front Pharmacol"},{"key":"4332_CR37","doi-asserted-by":"publisher","first-page":"107556","DOI":"10.1016\/j.bioorg.2024.107556","volume":"151","author":"J Wu","year":"2024","unstructured":"Wu J, Wang X, Yao Y, Du N, Duan L, Gong P. Design, synthesis and antitumor activities of phthalazinone derivatives as PARP-1 inhibitors and PARP-1\/HDAC-1 inhibitors. Bioorg Chem. 2024;151:107556.","journal-title":"Bioorg Chem"},{"key":"4332_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.afnr.2017.11.004","volume":"83","author":"RP Bird","year":"2018","unstructured":"Bird RP. The emerging role of vitamin B6 in inflammation and carcinogenesis. Adv Food Nutr Res. 2018;83:151\u201394.","journal-title":"Adv Food Nutr Res"},{"issue":"2","key":"4332_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00394-021-02665-2","volume":"61","author":"T Kumrungsee","year":"2022","unstructured":"Kumrungsee T, Peipei Z, Yanaka N, Suda T, Kato N. Emerging cardioprotective mechanisms of vitamin B6: a narrative review. Eur J Nutr. 2022;61(2):605\u201313.","journal-title":"Eur J Nutr"},{"issue":"2","key":"4332_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/ajcn\/nqac090","volume":"116","author":"AN Holowatyj","year":"2022","unstructured":"Holowatyj AN, Ose J, Gigic B, Lin T, Ulvik A, Geijsen A, et al. Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer. Am J Clin Nutr. 2022;116(2):303\u201313.","journal-title":"Am J Clin Nutr"},{"key":"4332_CR41","doi-asserted-by":"publisher","first-page":"837669","DOI":"10.3389\/fimmu.2022.837669","volume":"13","author":"D Bargiela","year":"2022","unstructured":"Bargiela D, Cunha PP, Veli\u00e7a P, Foskolou IP, Barbieri L, Rundqvist H, et al. Vitamin B6 metabolism determines T cell anti-tumor responses. Front Immunol. 2022;13:837669.","journal-title":"Front Immunol"},{"issue":"10","key":"4332_CR42","doi-asserted-by":"publisher","first-page":"e24704","DOI":"10.1002\/jcla.24704","volume":"36","author":"C Lin","year":"2022","unstructured":"Lin C, Ou Q. Emerging role of mitochondria in response to HBV infection. J Clin Lab Anal. 2022;36(10):e24704.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"4332_CR43","first-page":"3522","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Sun F, Yang W, Huang M, Pan C, Lin C. Clinical study of abnormal glucose metabolism and insulin resistance in patients with liver cirrhosis. Am J Transl Res. 2021;13(4):3522\u20138.","journal-title":"Am J Transl Res"},{"issue":"8","key":"4332_CR44","doi-asserted-by":"publisher","first-page":"102428","DOI":"10.1016\/j.clinre.2024.102428","volume":"48","author":"G Bale","year":"2024","unstructured":"Bale G, Clarembeau F, St\u00e4rkel P, Dahlqvist G, Horsmans Y, Lanthier N. Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clin Res Hepatol Gastroenterol. 2024;48(8):102428.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4332_CR45","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.molmet.2020.101154","volume":"45","author":"CE Shannon","year":"2021","unstructured":"Shannon CE, Ragavan M, Palavicini JP, Fourcaudot M, Bakewell TM, Valdez IA, et al. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease. Mol Metab. 2021;45:101154.","journal-title":"Mol Metab"},{"issue":"1","key":"4332_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13045-022-01358-5","volume":"15","author":"X Zhong","year":"2022","unstructured":"Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao S, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15(1):160.","journal-title":"J Hematol Oncol"},{"key":"4332_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-65768-0_1","volume":"1311","author":"S Bose","year":"2021","unstructured":"Bose S, Zhang C, Le A. Glucose metabolism in cancer: the Warburg effect and beyond. Adv Exp Med Biol. 2021;1311:3\u201315.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"4332_CR48","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/14737159.2022.2065196","volume":"22","author":"GM Nava","year":"2022","unstructured":"Nava GM, Madrigal Perez LA. Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer. Expert Rev Mol Diagn. 2022;22(4):439\u201347.","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"4332_CR49","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3390\/ijms25063142","volume":"25","author":"I Barba","year":"2024","unstructured":"Barba I, Carrillo-Bosch L, Seoane J. Targeting the warburg effect in cancer: where do we stand? Int J Mol Sci. 2024;25(6):3142.","journal-title":"Int J Mol Sci"},{"issue":"44","key":"4332_CR50","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1038\/s41388-019-0932-1","volume":"38","author":"K Tang","year":"2019","unstructured":"Tang K, Yu Y, Zhu L, Xu P, Chen J, Ma J, et al. Hypoxia-reprogrammed tricarboxylic acid cycle promotes the growth of human breast tumorigenic cells. Oncogene. 2019;38(44):6970\u201384.","journal-title":"Oncogene"},{"key":"4332_CR51","doi-asserted-by":"publisher","first-page":"18175","DOI":"10.1038\/srep18175","volume":"5","author":"R Gao","year":"2015","unstructured":"Gao R, Cheng J, Fan C, Shi X, Cao Y, Sun B, et al. Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma. Sci Rep. 2015;5:18175.","journal-title":"Sci Rep"},{"key":"4332_CR52","doi-asserted-by":"publisher","first-page":"42710","DOI":"10.1038\/srep42710","volume":"7","author":"T Wu","year":"2017","unstructured":"Wu T, Zheng X, Yang M, Zhao A, Li M, Chen T, et al. Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated cirrhosis and carcinoma patients. Sci Rep. 2017;7:42710.","journal-title":"Sci Rep"},{"issue":"14","key":"4332_CR53","doi-asserted-by":"publisher","first-page":"14949","DOI":"10.18632\/aging.103554","volume":"12","author":"FF Cai","year":"2020","unstructured":"Cai FF, Song YN, Lu YY, Zhang Y, Hu YY, Su SB. Analysis of plasma metabolic profile, characteristics and enzymes in the progression from chronic hepatitis B to hepatocellular carcinoma. Aging (Albany NY). 2020;12(14):14949\u201365.","journal-title":"Aging (Albany NY)"},{"key":"4332_CR54","doi-asserted-by":"publisher","first-page":"115900","DOI":"10.1016\/j.jpba.2023.115900","volume":"239","author":"X Ye","year":"2024","unstructured":"Ye X, He X, Hu Z, Zheng F, Huang X, Xie X, et al. Metabolomic analysis identifies dysregulation of lipid metabolism in the immune clearance phase of chronic hepatitis B patients. J Pharm Biomed Anal. 2024;239:115900.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"4332_CR55","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.iliver.2024.100142","volume":"4","author":"S Yu","year":"2025","unstructured":"Yu S, Wang S, Li J, Zheng H, Li P, Rong W, et al. Detection of metabolic signatures implicated in the progression from hepatitis to cirrhosis to hepatocellular carcinoma. Iliver. 2025;4(1):100142.","journal-title":"Iliver"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04332-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04332-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04332-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:03:14Z","timestamp":1761044594000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04332-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4332"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04332-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"25 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and the Declaration of Istanbul, and was approved by the Ethics Committee of Hunan Provincial People's Hospital, which granted a waiver of informed consent. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"744"}}